Rexahn Pharmaceuticals is a tiny biotech company seeking to develop several cancer drugs. With the stock price near $1, is it worth taking a swing at? Read More
Scott Chan moved from China to the U.S. with family at the age of ten. He passed the rigorous entrance exam and attended the merit-based Stuyvesant High School, widely held to be best public school in New York City. He earned undergraduate degrees from New York University followed by an MBA degree from the Zicklin School of Business at Baruch College.
Shortly thereafter Scott partnered with Dr. Stephen Leeb on numerous financial publications. Today, he serves as the lead analyst for Real World Investing and The Complete Investor.
Mr. Chan is an avid baseball fan and enjoys outdoor activities in his spare time. A multicultural person, he reads Chinese and speaks fluent Mandarin and Cantonese Chinese.
After years of climbing, Tencent stock has taken it on the chin. Will this online gaming and social networking behemoth bounce back, or is it game over? Read More
Renewable energy "YieldCos," which enjoy predictable revenue flow, are able to pay generous but steady cash distributions to investors. Read More
The adage that there is no such thing as a riskless investment is generally true. There’s a correlation between risk and reward. If you want greater return potential on your investment, you will usually have to take on greater risk. Even Treasury bonds, issued by the U.S. government, carry a… Read More